Biliary Inflammation and Biliary Carcinogenesis

  • Tomoo Kitajima
  • Yoshitsugu Tajima
  • Kei Matsuo
  • Tamotsu Kuroki
  • Shinya Onizuka
  • Yoshito Ikematsu
  • Sumihiro Matsuzaki
  • Takashi Kanematsu

Biliary carcinoma has been reported as a late complication of bilioenterostomy. The present study was designed to find out if bilioenterostomy promotes biliary carcinogenesis, and to clarify the relationship between biliary inflammation and biliary carcinogenesis in hamsters. Syrian hamsters were subjected to simple laparotomy (SL), choledochoduodenostomy (CD), or choledochojejunostomy (CJ). All hamsters received subcutaneous injections of the chemical carcinogen, N-nitrosobis(2-oxopropyl)amine (BOP), and were killed 20 weeks after surgery. Neoplastic lesions in the biliary tree were examined histologically, and the presence and degree of cholangitis was evaluated with special reference to the biliary carcinogenesis. The incidence of bile duct carcinoma did not differ significantly among the three groups. However, numerous bile duct carcinomas were recognized in the bilioenterostomized animals, especially in the CJ group. Moreover, there was a significant correlation between biliary carcinogenesis and the presence of cholangitis in the CD and CJ groups, but not in the SL control group. Severe cholangitis was evident in the CJ group, and the number of biliary carcinomas was well correlated with the degree of cholangitis. These findings suggest that the risk of carcinoma in the biliary tract is increased when cholangitis persists after biliary reconstruction.


Bile Duct Biliary Tract Choledochal Cyst Extrahepatic Bile Duct Bile Duct Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tocchi A, Costa G, Lepre L, Liotta G, Mazzoni G, Sita A. The long-term outcome of hepati-cojejunostomy in the treatment of benign bile duct strictures. Ann Surg 1996 224:162–167.PubMedCrossRefGoogle Scholar
  2. 2.
    Rothlin MA, Lopfe M, Schlumpf R, Largiader F. Long-term results of hepaticojejunostomy for benign lesions of the bile ducts. Am J Surg 1998 175:22–26.PubMedCrossRefGoogle Scholar
  3. 3.
    Saing H, Han H, Chan KL, Lam W, Chan FL, Cheng W, Tam PK. Early and late results of excision of choledochal cysts. J Pediatr Surg 1997 32:1563–1566.PubMedCrossRefGoogle Scholar
  4. 4.
    Sakaguchi T, Suzuki S, Suzuki A, Fukumoto K, Jindo O, Ota S, Inaba K, Kikuyama M, Nakamura S, Konno H. Late postoperative complications in patients with pancreaticobiliary maljunction. Hepatogastroenterology 2007 54:585–589.PubMedGoogle Scholar
  5. 5.
    Coyle KA, Bradley EL III. Cholangiocarcinoma developing after simple excision of a type II choledochal cyst. South Med J 1992 85:540–544.PubMedCrossRefGoogle Scholar
  6. 6.
    Watanabe Y, Toki A, Todani T. Bile duct cancer developed after cyst excision for choledochal cyst. J Hep Bil Pancr Surg 1999 6:207–212.CrossRefGoogle Scholar
  7. 7.
    Strong RW. Late bile duct cancer complicating biliary-enteric anastomosis for benign disease. Am J Surg 1999 177:472–474.PubMedCrossRefGoogle Scholar
  8. 8.
    Tsuchiya R, Harada N, Ito T, Furukawa M, Yoshihiro I. Malignant tumors in choledochal cyst. Ann Surg 1977 186: 22–28.PubMedCrossRefGoogle Scholar
  9. 9.
    Todani T, Watanabe Y, Toki A, Urushihara N. Carcinoma related to choledocal cysts with internal drainage operations. Surg Gynecol Obstet 1987 164: 61–64.PubMedGoogle Scholar
  10. 10.
    Funabiki T, Matsubara T, Ochiai M, Marugami Y, Sakurai Y, Hasegawa S, Imazu H. Biliary carcinogenesis in pancreaticobilialy maljunction. J Hep Bil Pancr Surg 1997 4: 405–411.CrossRefGoogle Scholar
  11. 11.
    Hakamada K. Sasaki M. Endoh M. Itoh T. Morita T. Konn M. Late development of bile duct cancer after sphincteroplasty: a ten- to twenty-two-year follow-up study. Surgery 1997 121:488–492.PubMedCrossRefGoogle Scholar
  12. 12.
    Pour P, Althoff J, Kruger FW, Mohr U. A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine. J Natl Cancer Inst 1977 58:1449–1453.PubMedGoogle Scholar
  13. 13.
    Tajima Y, Eto T, Tsunoda T, Tomioka T, Inoue K, Fukahori T, Kanematsu T. Induction of extrahepatic biliary carcinoma by N-nitrosobis(2-oxopropyl)amine in hamsters given chole-cystoduodenostomy with dissection of the common duct. Jpn J Cancer Res 1994 85(8):780–788.PubMedGoogle Scholar
  14. 14.
    Ikematsu Y, Tomioka T, Yamanaka S, Tajima Y, Tsunoda T, Kanematsu T. Bilioenterostomy enhances biliary carcinogenesis in hamsters. Carcinogenesis 1996 17:1505–1509.PubMedCrossRefGoogle Scholar
  15. 15.
    Ahrens W, Timmer A, Vyberg M, Fletcher T, Guénel P, Merler E, Merletti F, Morales M, Olsson H, Olsen J, Hardell L, Kaerlev L, Raverdy N, Lynge E. Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study. Eur J Gastroenterol Hepatol 2007 19:615–617.Google Scholar
  16. 16.
    Sharma V, Chauhan VS, Nath G, Kumar A, Shukla VK. Role of bile bacteria in gallbladder carcinoma. Hepatogastroenterology 2007 54:1622–1625.PubMedGoogle Scholar
  17. 17.
    Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 1999 1:209–214.Google Scholar
  18. 18.
    Matsumoto K, Fujii H, Michalopoulos G, Fung JJ, Demetris AJ. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: IL-6, HGF, and EGF promote DNA synthesis in vitro. Hepatology 1994 20:376–382.PubMedCrossRefGoogle Scholar
  19. 19.
    Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994 368:339–342.PubMedCrossRefGoogle Scholar
  20. 20.
    Lotz M. Interleukin-6. Cancer Invest 1993 11:732–742.PubMedCrossRefGoogle Scholar
  21. 21.
    Goydos JS, Brumfield AM, Frezza E, Booth A, Lotze MT, Carty SE. Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker. Ann Surg 1998 227:398–404PubMedCrossRefGoogle Scholar
  22. 22.
    Heikkilä K, Ebrahim S, Lawlor DA. Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer 2008 44:937–945.PubMedCrossRefGoogle Scholar
  23. 23.
    Porta C, De Amici M, Quaglini S, Paglino C, Tagliani F, Boncimino A, Moratti R, Corazza GR. Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. Ann Oncol 2008 19:353–358.PubMedCrossRefGoogle Scholar
  24. 24.
    Kitajima T, Tajima Y, Onizuka S, Matsuzaki S, Matsuo K, Kanemastu T. Linkage of persistent cholangitis after bilioenterostomy with biliary carcinogenesis in hamsters. J Exp Clin Cancer Res 2000 19:453–458.PubMedGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Tomoo Kitajima
    • 1
  • Yoshitsugu Tajima
    • Kei Matsuo
      • 1
    • Tamotsu Kuroki
      • Shinya Onizuka
        • 2
      • Yoshito Ikematsu
        • 3
      • Sumihiro Matsuzaki
        • 4
      • Takashi Kanematsu
        1. 1.Department of SurgeryNagasaki Municipal HospitalNagasakiJapan
        2. 2.Department of SurgeryNational Hospital Organization Nagasaki Medical CenterNagasakiJapan
        3. 3.Department of SurgeryHamamatsu Medical CenterHamamatsuJapan
        4. 4.Department of SurgeryDialand Matsuzaki ClinicNagasakiJapan

        Personalised recommendations